FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/02/2024
Back to search
Official data from USPTO
QUADRATEK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
QUADRATEK
ST13
US500000079370605Class
5, 42
Filing
79370605
Registration
7431124
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
10/02/2024
Trademark type
Word
Nice classes
5, 42
Filing date
03/02/2023
Registration date
07/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/02/2024
Last transaction
07/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CN
Examiner
JONES, JACQUELYN
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Inmagene Biopharmaceuticals (Hangzhou) Co., Ltd.
Representatives
INTELIGHT IP LAW FIRM
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for the treatment and control of inflammation and immune system related diseases; pharmaceutical preparations for inflammation and immune system related diseases; chemical preparations for pharmaceutical or medical purposesfor inflammation and immune system related diseases; biological preparations for the treatment and control of inflammation and immune system related diseases; allergy relief medication; allergy medication
Class 42
Biotechnology research; biomedical research services; pharmaceutical research services; scientific research and development; research and development of new products for others; scientific laboratory services; quality control for others; quality evaluation services for the medical and anesthesia industries; scientific research and development in the field of immunity and antibody screening; research and development services in the field of antibodies
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/02/2024
GPNX
NOTIFICATION PROCESSED BY IB
04/16/2024
PUBO
PUBLISHED FOR OPPOSITION
04/16/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/27/2024
NPUB
NOTICE OF PUBLICATION
03/27/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/27/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/11/2024
RFNT
REFUSAL PROCESSED BY IB
02/14/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/19/2024
RFRR
REFUSAL PROCESSED BY MPU
01/19/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/02/2023
CNRT
NON-FINAL ACTION WRITTEN
12/01/2023
DOCK
ASSIGNED TO EXAMINER
12/01/2023
MAFR
APPLICATION FILING RECEIPT MAILED
06/06/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/01/2023
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
06/01/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/25/2023
Continuous trademark protection
Get notified about every new filing that threatens QUADRATEK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.